← All trials
NCT04590196
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2020
- Primary completion
- Nov 1, 2021
- Completion date
- Nov 1, 2021
- First posted
- Oct 19, 2020
- Last posted
- Oct 19, 2020
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Illinois at ChicagoLead sponsor
- University of Illinois at ChicagoReponsible party - principal investigator
- University of Illinois at ChicagoOverall official - principal investigator
- VitreoRetinal Surgery, PACollaborator
- Illinois Society for the Prevention of BlindnessCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.